Mesirow Financial Investment Management Inc. Buys 251 Shares of Danaher Corporation $DHR

Mesirow Financial Investment Management Inc. increased its stake in Danaher Corporation (NYSE:DHR) by 1.7% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 15,227 shares of the conglomerate’s stock after purchasing an additional 251 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in Danaher were worth $3,008,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Boyd Watterson Asset Management LLC OH raised its holdings in Danaher by 2.1% in the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after purchasing an additional 51 shares during the period. Worth Financial Advisory Group LLC raised its holdings in Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after acquiring an additional 53 shares during the period. 1834 Investment Advisors Co. raised its holdings in Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 54 shares during the period. Bruce G. Allen Investments LLC raised its holdings in Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after acquiring an additional 54 shares during the period. Finally, Cassaday & Co Wealth Management LLC raised its holdings in Danaher by 1.2% during the first quarter. Cassaday & Co Wealth Management LLC now owns 4,717 shares of the conglomerate’s stock valued at $967,000 after acquiring an additional 56 shares during the period. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on DHR shares. Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Barclays raised their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Redburn Partners set a $220.00 price target on Danaher in a report on Wednesday, October 8th. Guggenheim reissued a “buy” rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a report on Thursday, October 23rd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Trading Up 0.3%

Shares of DHR stock opened at $215.63 on Friday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock’s 50-day moving average price is $203.41 and its 200-day moving average price is $199.47. The stock has a market capitalization of $152.31 billion, a price-to-earnings ratio of 44.46, a price-to-earnings-growth ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the firm posted $1.71 earnings per share. The business’s revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were given a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.